Skip to main content
OpenTrials

Clinical trial condition

IgG Monoclonal Gammopathy of Uncertain Significance

Explore clinical trials studying IgG Monoclonal Gammopathy of Uncertain Significance. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

IgG Monoclonal Gammopathy of Uncertain Significance trial results

Recruiting

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592

Conditions
B-cell Malignancy, Low-grade, Blood Protein Disorders, Bone Marrow Diseases, +36 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute at St. Elizabeth's Brighton, Massachusetts, United States
  • Dana Farber Cancer Institute at Merrimack Valley Methuen, Massachusetts, United States
  • Dana Farber Cancer Institute at Milford Regional Medical Center Milford, Massachusetts, United States
View Trial Details

Related conditions